SynthesisFrontiers in oncology2022

Comparative Efficacy and Safety of Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Ovarian Cancer: A Systematic Review and Network Meta-Analysis.

Jing Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.